Ian Yang
- The TNF-derived TIP peptide reduces lung dysfunction in experimental influenza A virus infectionBy Rudolf Lucas, Guang Yang, Supriya Sridhar, Zachary Traylor, Hamid Hossain, Bernhard Fischer, Trinad Chakraborty and Ian DavisRudolf Lucas1Vascular Biology Center, Pharmacology and Toxicology, Georgia Health Sciences University, Augusta, GA, United StatesGuang Yang1Vascular Biology Center, Pharmacology and Toxicology, Georgia Health Sciences University, Augusta, GA, United StatesSupriya Sridhar1Vascular Biology Center, Pharmacology and Toxicology, Georgia Health Sciences University, Augusta, GA, United StatesZachary Traylor2Veterinary Biosciences, Ohio State University, Columbus, OH, United StatesHamid Hossain3Medical Microbiology, Justus-Liebig University, Giessen, Hessen, GermanyBernhard Fischer4Research and Development, Apeptico, Vienna, AustriaTrinad Chakraborty3Medical Microbiology, Justus-Liebig University, Giessen, Hessen, GermanyIan Davis2Veterinary Biosciences, Ohio State University, Columbus, OH, United States
- Dysregulated miRNAs and their predicted mRNA targets in emphysematous lungsBy Santiyagu Savarimuthu Francis, Morgan Davidson, Rayleen Bowman, Nicholas Hayward, Kwun Fong and Ian YangSantiyagu Savarimuthu FrancisMorgan DavidsonRayleen BowmanNicholas Hayward3Oncogenomics Laboratory, Queensland Institute of Medical Research, Brisbane, QLD, AustraliaKwun Fong
- Electronic nose detects early stage and peripheral lung cancersBy Annette Dent, Rayleen Bowman, Paul Zimmerman, Ian Yang and Kwun FongAnnette Dent1Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, Australia2School of Medicine, The University of Queensland, Brisbane, QLD, AustraliaRayleen Bowman1Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, Australia2School of Medicine, The University of Queensland, Brisbane, QLD, AustraliaPaul Zimmerman1Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, Australia2School of Medicine, The University of Queensland, Brisbane, QLD, AustraliaIan Yang1Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, Australia2School of Medicine, The University of Queensland, Brisbane, QLD, AustraliaKwun Fong1Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, Australia2School of Medicine, The University of Queensland, Brisbane, QLD, Australia
- Effects of diesel exhaust particles on human bronchial epithelial cells at air-liquid interfaceBy Annalicia Vaughan, Svetlana Stevanovic, Branka Miljevic, Zoran Ristovski, Felicia Goh, Vandana Relan, Leanne Morrison, Rayleen Bowman, Kwun Fong and Ian YangAnnalicia Vaughan1UQ Thoracic Research Centre, The University of Queensland, Brisbane, QLD, Australia2Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, AustraliaSvetlana Stevanovic3International Laboratory for Air Quality and Health, Queensland University of Technology, Brisbane, QLD, AustraliaBranka Miljevic3International Laboratory for Air Quality and Health, Queensland University of Technology, Brisbane, QLD, AustraliaZoran Ristovski3International Laboratory for Air Quality and Health, Queensland University of Technology, Brisbane, QLD, AustraliaFelicia Goh1UQ Thoracic Research Centre, The University of Queensland, Brisbane, QLD, Australia2Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, AustraliaVandana Relan1UQ Thoracic Research Centre, The University of Queensland, Brisbane, QLD, Australia2Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, AustraliaLeanne Morrison1UQ Thoracic Research Centre, The University of Queensland, Brisbane, QLD, Australia2Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, AustraliaRayleen Bowman1UQ Thoracic Research Centre, The University of Queensland, Brisbane, QLD, Australia2Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, AustraliaKwun Fong1UQ Thoracic Research Centre, The University of Queensland, Brisbane, QLD, Australia2Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, AustraliaIan Yang1UQ Thoracic Research Centre, The University of Queensland, Brisbane, QLD, Australia2Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, Australia
- Blood cytotoxic/pro-inflammatory mediators in severe asthmaBy Sandra Hodge, Greg Hodge, Jodie L. Simpson, Ian Yang, John Upham, Alan James, Peter G. Gibson and Paul N. ReynoldsSandra Hodge1Lung Research and Thoracic Medicine, Hanson Institute and Royal Adelaide Hospital, Adelaide, South Australia, Australia2School of Medicine, The University of Adelaide, Adelaide, South Australia, AustraliaGreg Hodge1Lung Research and Thoracic Medicine, Hanson Institute and Royal Adelaide Hospital, Adelaide, South Australia, Australia2School of Medicine, The University of Adelaide, Adelaide, South Australia, AustraliaJodie L. Simpson3Centre for Asthma and Respiratory Disease, The University of Newcastle, Newcastle, NSW, Australia4Respiratory and Sleep Medicine, Hunter Medical Research Institute, Newcastle, NSW, AustraliaIan Yang5School of Medicine, The University of Queensland, Brisbane, Queensland, Australia6Thoracic Medicine, The Prince Charles Hospital, Brisbane, Queensland, AustraliaJohn Upham5School of Medicine, The University of Queensland, Brisbane, Queensland, Australia7Respiratory Medicine, Princess Alexandra Hospital, Brisbane, Queensland, AustraliaAlan James8Pulmonary Physiology and Sleep Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, AustraliaPeter G. Gibson3Centre for Asthma and Respiratory Disease, The University of Newcastle, Newcastle, NSW, Australia4Respiratory and Sleep Medicine, Hunter Medical Research Institute, Newcastle, NSW, AustraliaPaul N. Reynolds1Lung Research and Thoracic Medicine, Hanson Institute and Royal Adelaide Hospital, Adelaide, South Australia, Australia2School of Medicine, The University of Adelaide, Adelaide, South Australia, Australia
- Electronic nose as a screening tool for early stage lung cancerBy Annette Dent, Rayleen Bowman, Paul Zimmerman, Ian Yang and Kwun FongAnnette Dent1Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia2School of Medicine, University of Queensland, Brisbane, Queensland, Australia3UQ Thoracic Research Centre, The Prince Charles Hospital, Brisbane, Queensland, AustraliaRayleen Bowman1Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia2School of Medicine, University of Queensland, Brisbane, Queensland, Australia3UQ Thoracic Research Centre, The Prince Charles Hospital, Brisbane, Queensland, AustraliaPaul Zimmerman1Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia2School of Medicine, University of Queensland, Brisbane, Queensland, Australia3UQ Thoracic Research Centre, The Prince Charles Hospital, Brisbane, Queensland, AustraliaIan Yang1Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia2School of Medicine, University of Queensland, Brisbane, Queensland, Australia3UQ Thoracic Research Centre, The Prince Charles Hospital, Brisbane, Queensland, AustraliaKwun Fong1Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia2School of Medicine, University of Queensland, Brisbane, Queensland, Australia3UQ Thoracic Research Centre, The Prince Charles Hospital, Brisbane, Queensland, Australia
- Safety and pharmacology of a soluble epoxide hydrolase inhibitorBy Aili Lazaar, Lucy Yang, Jon Robertson, Navin Goyal, Rebecca Boardley, Ruth Tal-Singer, Joseph Cheriyan, David Newby, Ian Wilkinson and Ruth MayerAili Lazaar1Respiratory Therapy Area, GlaxoSmithKline, King of Prussia, United StatesLucy Yang2Department of Medicine, Addenbrooke's Hospital, Cambridge, United KingdomJon Robertson3Clinical Statistics, GlaxoSmithKline, Stevenage, United KingdomNavin Goyal4Clinical Pharmacology, Modeling and Simulation, GlaxoSmithKline, King of Prussia, United StatesRebecca Boardley5Clinical Pharmacology Science & Study Operations, GlaxoSmithKline, Stevenage, United KingdomRuth Tal-Singer1Respiratory Therapy Area, GlaxoSmithKline, King of Prussia, United StatesJoseph Cheriyan2Department of Medicine, Addenbrooke's Hospital, Cambridge, United KingdomDavid Newby6Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United KingdomIan Wilkinson2Department of Medicine, Addenbrooke's Hospital, Cambridge, United KingdomRuth Mayer1Respiratory Therapy Area, GlaxoSmithKline, King of Prussia, United States
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.